Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges

Twenty-Four Months of Antipsychotic Treatment in Children and Adolescents With First Psychotic Episode

(2013) Ana Noguera et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Pediatric psychopharmacology: too much or too little?

(2013) Judith L. Rapoport   World Psychiatry

National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

(2012) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

The Relationship between Mental Health Diagnosis and Treatment with Second-Generation Antipsychotics over Time: A National Study of U.S. Medicaid-Enrolled Children

(2012) Meredith Matone et al.   HEALTH SERVICES RESEARCH

Risk of Hyperprolactinemia and Sexual Side Effects in Males 10–20 Years Old Diagnosed with Autism Spectrum Disorders or Disruptive Behavior Disorder and Treated with Risperidone

(2012) Yvette Roke et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Rate of Weight Gain and Cardiometabolic Abnormalities in Children and Adolescents

(2012) Chadi A. Calarge et al.   JOURNAL OF PEDIATRICS

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Child and adolescent neuropsychopharmacology: Now or never

(2011) Celso Arango   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies

(2011) Alessandro Zuddas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Conduct disorder and adult psychiatric diagnoses: Associations and gender differences in the U.S. adult population

(2011) Carmen Morcillo et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons

(2010) David Fraguas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: A review of current and potentially promising treatment options.

(2010) Robert M. Nevels et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Risperidone-Induced Weight Gain in Referred Children with Autism Spectrum Disorders Is Associated with a Common Polymorphism in the 5-Hydroxytryptamine 2C Receptor Gene

(2010) Pieter J. Hoekstra et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Long-term effectiveness of a parenting intervention for children at risk of developing conduct disorder

(2009) Tracey Bywater et al.   BRITISH JOURNAL OF PSYCHIATRY

Service utilization by children with conduct disorders: findings from the 2004 Great Britain child mental health survey

(2009) Raghuram Shivram et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns

(2009) Benedetto Vitiello et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents

(2009) Chadi A. Calarge et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Effect of Hyperprolactinemia During Development in Children and Adolescents

(2009) Christoph U. Correll   JOURNAL OF CLINICAL PSYCHIATRY

Metabolic and Hormonal Side Effects in Children and Adolescents Treated With Second-Generation Antipsychotics

(2009) David Fraguas et al.   JOURNAL OF CLINICAL PSYCHIATRY

Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents

(2009) Chadi A. Calarge et al.   Pharmacogenetics and Genomics

The Nisonger Child Behavior Rating Form: typical IQ version

(2008) Michael Aman et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Research Review: The importance of callous-unemotional traits for developmental models of aggressive and antisocial behavior

(2008) Paul J. Frick et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone

(2008) Christian Fleischhaker et al.   JOURNAL OF NEURAL TRANSMISSION

Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom

(2008) F. Rani et al.   PEDIATRICS

Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005

(2008) L. J. Kalverdijk et al.   PSYCHIATRIC SERVICES